Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. SURG
SURG logo

SURG Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Surgepays Inc (SURG) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.850
1 Day change
52 Week Range
3.470
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

SurgePays Inc (SURG) is not a strong buy candidate at this time for a beginner, long-term investor with $50,000-$100,000 available for investment. The stock lacks positive catalysts, has weak financial performance, and technical indicators suggest a bearish trend. Given the absence of significant trading signals or news, it is best to hold off on investing in this stock for now.

Technical Analysis

The MACD is positive and expanding, indicating slight bullish momentum. However, the RSI is neutral at 46.432, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with resistance at 0.917 and support at 0.766. Overall, the technical trend is bearish.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
7

Positive Catalysts

  • NULL identified. No recent news or significant trading trends from hedge funds or insiders. The stock has no recent congress trading data or influential figure activity.

Neutral/Negative Catalysts

  • Weak financial performance in Q3 2025, with a significant drop in net income (-47.54% YoY), EPS (-47.95% YoY), and gross margin (-91.23% YoY). The stock's trend analysis suggests a high probability of negative returns in the short and medium term (-0.49% next day, -0.88% next week, -9.57% next month).

Financial Performance

In Q3 2025, revenue increased significantly by 291.65% YoY to $18.68M. However, net income dropped to -$7.49M (-47.54% YoY), EPS declined to -0.38 (-47.95% YoY), and gross margin fell sharply to -14.92% (-91.23% YoY). The company is struggling with profitability despite revenue growth.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst ratings or price target changes available for SURG.

Wall Street analysts forecast SURG stock price to rise
2 Analyst Rating
Wall Street analysts forecast SURG stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.847
sliders
Low
9.75
Averages
9.75
High
9.75
Current: 0.847
sliders
Low
9.75
Averages
9.75
High
9.75
Ascendiant Capital
Edward Woo
Strong Buy
Maintains
$8.5 → $8.75
AI Analysis
2025-04-22
Reason
Ascendiant Capital
Edward Woo
Price Target
$8.5 → $8.75
AI Analysis
2025-04-22
Maintains
Strong Buy
Reason

People Also Watch